<?xml version="1.0" encoding="UTF-8"?>
<p id="par0340">The Fogarty-led MISMS and RAPIDD programs have been catalysts in advancing state-of-the-art global infectious disease modeling and training with tangible impacts in building capacity globally and guiding policies, such as defining age priority groups for epidemic and pandemic influenza vaccines, addressing optimal delivery of influenza vaccines in tropical and low-income countries, and highlighting gaps in measles vaccine coverage following the Ebola outbreak in West Africa. In addition to influencing policy, a major success of the MISMS and RAPIDD programs is reflected by the outstanding professional trajectories of their alumni, domestically and internationally, and the excellence and international scope of their publications (
 <xref rid="tbl0005" ref-type="table">Table 1</xref>, 
 <xref rid="tb0020" ref-type="boxed-text">Box 4</xref>). Of the more than 1400 publications of the MISMS and RAPIDD programs, which have been cited over 50,000 times, 28% include authors from LMICs. Many of the RAPIDD and MISMS trainees and collaborators are now established as senior researchers.
</p>
